Christoph Englert

Christoph Englert


Research Focus & Metrics

Academic Career Length

39Years (1988-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 May 1999 in Cell
Verified
Journal Article
Closed access
DHD.PAul Harkin
D.PAul Harkin
JBJames M Bean
James M Bean
DMDavid Miklos
David Miklos
YSYoung-Han Song
Young-Han Song
VTVivi B Truong
Vivi B Truong
DHDaniel A Haber
Daniel A Haber

12 January 2009 in Journal of Experimental Medicine
Verified
Journal Article
Open access
PDF file
RGRolf Gräbner
Rolf Gräbner
KLKatharina Lötzer
Katharina Lötzer
SDSandra Döpping
Sandra Döpping
MHMarkus Hildner
Markus Hildner
DRDörte Radke
Dörte Radke
AHAndreas JR Habenicht
Andreas JR Habenicht
Atherosclerosis involves a macrophage-rich inflammation in the aortic intima. It is increasingly recognized that this intimal inflammation is paralleled over time by a distinct inflammatory reaction in adjacent adventitia. Though cross talk between the coordinated inflammatory foci in the intima and the adventitia seems implicit, the mechanism(s) underlying their communication is unclear. Here, using detailed imaging analysis, microarray analyses, laser-capture microdissection, adoptive lymphocyte transfers, and functional blocking studies, we undertook to identify this mechanism. We show that in aged apoE−/− mice, medial smooth muscle cells (SMCs) beneath intimal plaques in abdominal aortae become activated through lymphotoxin β receptor (LTβR) to express the lymphorganogenic chemokines CXCL13 and CCL21. These signals in turn trigger the development of elaborate bona fide adventitial aortic tertiary lymphoid organs (ATLOs) containing functional conduit meshworks, germinal centers within B cell follicles, clusters of plasma cells, high endothelial venules (HEVs) in T cell areas, and a high proportion of T regulatory cells. Treatment of apoE−/− mice with LTβR-Ig to interrupt LTβR signaling in SMCs strongly reduced HEV abundance, CXCL13, and CCL21 expression, and disrupted the structure and maintenance of ATLOs. Thus, the LTβR pathway has a major role in shaping the immunological characteristics and overall integrity of the arterial wall.

1 December 2015 in Cell
Verified
Journal Article
Closed access
KRKathrin Reichwald
Kathrin Reichwald
APAndreas Petzold
Andreas Petzold
PKPhilipp Koch
Philipp Koch
BDBryan R. Downie
Bryan R. Downie
NHNils Hartmann
Nils Hartmann
MPMatthias Platzer
Matthias Platzer

1 January 2006 in Biology of Reproduction
Verified
Journal Article
Open access
PDF file
Francisco Javier Barrionuevo JimenezFrancisco Javier Barrionuevo Jimenez
Francisco Javier Barrionuevo Jimenez
SBStefan Bagheri-Fam
Stefan Bagheri-Fam
JKJürGen Klattig
JürGen Klattig
RKRalf Kist
Ralf Kist
MTMakoto M. Taketo
Makoto M. Taketo
GSGerd Scherer
Gerd Scherer
In the presence of the Y-chromosomal gene Sry, the bipotential mouse gonads develop as testes rather than as ovaries. The autosomal gene Sox9, a like

26 January 2011 in Nature
Verified
Journal Article
Closed access
PDF file
CDCuong Q. Diep
Cuong Q. Diep
DMDongdong Ma
Dongdong Ma
RDRahul C. Deo
Rahul C. Deo
THTeresa M. Holm
Teresa M. Holm
RNRichard W. Naylor
Richard W. Naylor
ADAlan Davidson
Alan Davidson

18 January 1996 in New England Journal of Medicine
Verified
Journal Article
Closed access
PDF file
MFMichael G. FitzGerald
Michael G. FitzGerald
DMDeborah J. MacDonald
Deborah J. MacDonald
Michael W. KrainerMichael W. Krainer
Michael W. Krainer
IHIngrid Hoover
Ingrid Hoover
EOErin O'NEil
Erin O'NEil
DHDaniel A. Haber
Daniel A. Haber
Mutations in a germ-line allele of the BRCA1 gene contribute to the familial breast cancer syndrome. However, the prevalence of these mutations is unknown in women with breast cancer who do not have the features of this familial syndrome. We sought BRCA1 mutations in women who were given a diagnosis of breast cancer at an early age, because early onset is characteristic of a genetic predisposition to cancer. Clinical information and peripheral-blood mononuclear cells were obtained from 418 women from the Boston metropolitan area in whom breast cancer was diagnosed at or before the age of 40. A comprehensive BRCA1 mutational analysis, involving automated nucleotide sequencing and a protein-truncation assay, was undertaken in 30 of these women, who had breast cancer before the age of 30. In addition, the BRCA1 mutation 185delAG, which is prevalent in the Ashkenazi Jewish population, was sought with an allele-specific polymerase-chain-reaction assay in 39 Jewish women among the 418 women who had breast cancer at or before the age of 40. Among 30 women with breast cancer before the age of 30, 4 (13 percent) had definite, chain-terminating mutations and 1 had a missense mutation. Two of the four Jewish women in this cohort had the 185delAG mutation. Among the 39 Jewish women with breast cancer at or before the age of 40, 8 (21 percent) carried the 185delAG mutation (95 percent confidence interval, 9 to 36 percent). Germ-line BRCA1 mutations can be present in young women with breast cancer who do not belong to families with multiple affected members. The specific BRCA1 mutation known as 185delAG is strongly associated with the onset of breast cancer in Jewish women before the age of 40.